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A meta-analysis concluded that depression is associated with poor glycaemic control in Type 2 diabetes (DM2).
In DM2 patients with deteriorating glycaemic control, the initiation of insulin therapy is often postponed. The aim of the
present study was to determine whether symptoms of depression and diabetes-specific emotional distress are associated




We collected cross-sectional data in two outpatient university clinics in Istanbul, Turkey. The study sample
consisted of 154 insulin-naïve patients with DM2. A self-report questionnaire was used to obtain demographic and clin-
ical data. Main instruments were the Centre for Epidemiologic Studies Depression Scale, (CES-D), the Problem Areas In




Analysis of variance revealed that patients with a higher depression score rated insulin therapy significantly
more negative then patients with lower depression scores. Moreover, 47% of patients with a high depression score had a
negative appraisal of insulin therapy on 7 or more of the 20 ITAS-items, compared to 25 to 29% of those with low-
moderate depression scores. Multiple regression analyses showed that a negative appraisal of insulin therapy was





Our results suggest that in insulin-naïve Type 2 diabetes patients, higher levels of depression and diabetes-
distress tend to be associated with more negative beliefs about insulin. Whether these negative attitudes translate into
postponing initiation of insulin therapy needs to be tested in longitudinal research.












Depression can be regarded as a serious and common com-
plication of diabetes, as a recent meta-analysis concluded that
depression is 2–3 times more prevalent in people with diabetes
than in the general population, affecting 10–15% of the diabetes
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with impaired glycaemic control, and as a consequence depressed
diabetes patients are at a higher risk for long-term complica-
tions of the disease [2,3]
Although results of the United Kingdom Prospective Diabetes
Study (UKPDS) have shown convincingly that good glycaemic
control can prevent or delay the onset of diabetes complications
in Type 2 diabetes patients, a reluctance to start insulin therapy
has been observed in many patients with Type 2 diabetes [4–7].
Only a few studies have reported results regarding the
prevalence of negative appraisals of insulin, or ‘psychological
insulin resistance’. For example, in the UKPDS, 27% of the
patients randomized to insulin therapy initially refused insulin,
compared to 7% in the Glibenclamide group and 13% in the





comparable results, showing that about 28% of insulin naive
diabetes patients reported to be unwilling to begin insulin if
prescribed [6]. Hence, these results suggest that considerably
strong, negative appraisals regarding insulin therapy exist in
about one third of the insulin-naïve patients. However, the
determinants of a negative appraisal of insulin therapy are still
unclear. A negative appraisal of insulin therapy was found to be
more common in women compared to men (31% versus 21%)
and in ethnic minorities versus whites (35% versus 22%) [6].
Besides low mood, depressed patients often complain about
reduced energy and low self-efficacy, resulting in difficulty
finishing tasks and a decreased motivation in undertaking
new projects [8]. We can therefore hypothesize that higher
levels of depressive symptoms are associated with a more
negative appraisal of insulin therapy, that could result in
postponing initiation of insulin treatment. In this cross-
sectional study we aimed to test whether depression and
diabetes distress are associated with a more negative attitude
towards insulin in a group patients with Type 2 diabetes
treated with diet and/or oral agents.
 
Research design and methods
 
This study was conducted in two outpatient clinics in Istanbul,










Medical Faculty Hospital is a tertiary clinic serving approxi-
mately 10 000 patients with diabetes annually.
We aimed to include a sample of at least 150 insulin-naïve
patients with Type 2 diabetes. Therefore, we invited consecutive
patients with Type 2 diabetes mellitus who were treated with a
diet and/or oral agents. Exclusion criteria for this study were
being illiterate or not being able to read due to vision problems.
All subjects gave written informed consent and the Ethical Re-









Demographic data and information regarding medical treatments





 values were collected using the medical charts of participants.
 
Appraisal of Insulin Therapy Scale
 
The Insulin Treatment Appraisal Scale [ITAS] has been developed
to assess attitudes towards insulin treatment and contains 20
items (16 negative, 4 positive statements) that are scored on a 5
point Likert scale, ranging from strongly disagree to strongly
agree. The topics covered in ITAS include for example that
insulin signifies: feeling sicker, being more dependent, having a
higher risk of hypoglycemia, painful injections, being restricted in
daily life, being protected from complications or feeling more
energetic. The ITAS appeared to have satisfactory psychometric
qualities for diagnostic and research purposes in relation to
perceptual barriers to insulin therapy [9]. To date, Cronbach’s
alpha was 0.88 and item-total correlations were all larger than
0.25. The total ITAS score is calculated as the sum of the 20
items, where a higher score indicates a more negative perception
of insulin therapy. In the present samples, Cronbach’s alpha









Depression was assessed using the Turkish version of the
Centre for Epidemiologic Studies Depression Scale (CES-D).
This is a 20-item, self-report scale that asks respondents to
indicate the frequency of occurrence of 20 depression symptoms
during the last week. The instrument uses a four-point response
set, ranging from ‘rarely or none of the time’ to ‘most or all of
the time’. Higher scores indicate more depressive symptoms
and a cut-off point of 16 or more is generally accepted as in-





The Problem Areas in Diabetes (PAID) scale is a 20 item,
self-report scale that asks individuals to rate how much of a
problem, on a five-point scale (‘not a problem’ to ‘serious problem’)
they find each of the 20 issues raised [13]. The items consist
of 20 statements that Polonsky and colleagues identified as
common negative emotions related to living with diabetes,
for example ‘feeling alone with diabetes’, ‘worrying about the
future and the possibility of serious complications’. The PAID
scores are summed and transformed to a 0–100 scale, with
higher scores indicating higher emotional problems. The ITAS
and the PAID were translated from English to Turkish by
two authors (CM and ÇK), who are both fluent in English and
Turkish. Back translations by another translator who was not





SPSS version 12 for Windows was used to carry out statistical
analyses. In case of missing values on the CESD and the ITAS,
a maximum number of 3 items were estimated using the mean
of the other completed items of that particular questionnaire.
Firstly, demographic, clinical and depression data of two
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clinics were compared, using the Chi-square tests for dichotomous
variables and t-tests and analysis of variance for variables
with a continuous distribution. These analyses were performed
separately for men and women. For all statistical testing, we
used two-sided hypothesis testing with an alpha level of 0.05.
To explore whether demographic variables (gender, age, low
education and duration of diabetes) and depression scores were
associated with appraisal of insulin therapy, stepwise multiple
linear regression analyses were performed. Total ITAS score
was entered as the dependent variable in all regression analyses.
Variance inflation factor (VIF) and tolerance values were used
to indicate multicollinearity. We used the rule of thumb that
tolerance should be > 0.20 and VIF < 4 to suggest no multicol-
linearity. We used combined data of both clinics to determine
the percentages of subjects who responded to individual
ITAS items with: ‘somewhat agree’ or ‘strongly agree’. These
percentages are described for each of the 20 ITAS items, in
three subgroups of patients with different CES-D depression
scores: 0–15 (low/moderate), 16–23 (elevated depressive






The total study sample comprised of 154 subjects, of whom
84 were women (55%). A total number of 220 patients were
invited, and 154 patients (70%) agreed to participate and met
the inclusion criteria. A total 30% of the invited patients did
not want to participate or could not participate because being
illiterate or not able to read without an optical device. The









years (total ranging from 28 to 81 years). There were no sig-
nificant differences between the two clinics regarding gender,
age or duration of diabetes. A considerable percentage of the
sample appeared to be highly educated (41%). Compared to
the male participants, women had a significantly lower level
of education. The majority of the individuals were married





(4.8–10.0), 63% responded not to have a complication of
diabetes. The percentage of missing values was for the CES-D
was 1.2% and for the ITAS 2.4%. Compared to the patients















 < 0.05). As to be expected, women had higher mean
depression scores compared to male participants (Table 1).
 
Associations between depression and the appraisal of insulin 
therapy
 




 10. There was no significant
difference between male and female participants regarding
the appraisal of insulin therapy. The total ITAS score, was










Next, in Table 2 it is shown that patients with a high depres-
sion score rated insulin therapy more negatively on more than
half of the items, compared to patients with lower depression
scores. Moreover, 47% of patients with a high depression
score had a negative appraisal of insulin therapy on 7 or more
ITAS-items, compared to 25 to 29% of those with low-moderate





Table 3 shows the results of stepwise, multiple regression
analyses that were conducted to evaluate whether demographic
data, symptoms of depression and diabetes-specific emotional
distress were associated with a negative appraisal of insulin
therapy (ITAS). Values for VIF and tolerance did not indicate
multicollinearity problems. The first regression model included
four demographic variables: being female, low level of educa-
tion, age and duration of diabetes. In this model, patients with
a low education tended to have a more negative appraisal of




 = 0.08), while the other variables
were not significantly associated with appraisal of insulin.
In the second model, depression was significantly associated




 = 0.02). In the third model, diabetes-specific emotional
distress was added to the analysis: this resulted in a large drop
of the Beta between depression and negative insulin-appraisal




The aim of our research was to study whether higher levels of
depression symptoms and diabetes-specific distress are associated
with a more negative appraisal of insulin therapy, underlying
a reluctance to start insulin. Indeed we found that patients
with Type 2 diabetes who reported increased levels of depres-
sive symptoms had significantly more negative beliefs about
insulin therapy, as measured with the ITAS, compared to non
depressed patients. In the linear regression analyses, depres-
sion symptomatology was found to be positively associated
with a more negative appraisal of insulin therapy. Adjustment
for diabetes-specific emotional problems lowered this to
almost zero. Moreover, the positive association between
diabetes-distress and a negative insulin appraisal was con-
siderably stronger than the association with depression. This
suggests that in insulin-naïve Type 2 diabetes patients, higher
levels of diabetes-distress directly contribute to more negative
expectations of insulin therapy.
It is important to note that both outpatient samples in our
studywere in rather good control, with no apparent need to
start insulin therapy. Nevertheless, like in the United Kingdom
[4] and in the U.S.A. [6,7], a considerable number of the
Turkish diabetes patients in our study had negative appraisals
of insulin therapy. The patients’ reasons for disliking insulin
therapy clearly extend beyond fear of injections alone. Other
factors, such as worries about the impact of insulin therapy on
the social environment and feelings that insulin therapy
signifies that one has failed to manage diabetes with diet/
tablets also appear to play a role.
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In the present study, we found that 48–68% of the participants
agreed to some extend that taking insulin indicates a personal
failure, which is in concert with findings from the DAWN
study, where 58% of the patients agreed with a comparable
statement [7,14]. Requiring insulin therapy is linked to a sense
of personal failure, possibly fuelled by common physician
practice worldwide, where the prospect of insulin therapy is
used as a kind of threat to motivate better patient cooperation
[6]. In the present study a substantial number of patients
(43–60%) stated that insulin therapy would cause family and




[6] did not report this response, possibly related to
differences in culture [15,16].
Patients with higher levels of depression, scored highest on
the ITAS item ‘Managing insulin injections takes a lot of time
and energy’. The fact that depressed patients tend to view insu-
lin injections as (too) complex and burdensome, is in line with
our expectations, as depression is characterized by low energy,
cognitive difficulties, low outcome expectancies and self-esteem
[8]. Also, patients with a low education believed insulin therapy
to be difficult and demanding, drawing attention to the importance
of diabetes knowledge and a correct understanding of the
pathophysiology and treatment of Type 2 diabetes. The fact
that the DAWN study [7] did not find a relationship between
education and negative attitudes towards insulin may be
related to a difference in measurement. Where we used a
comprehensive questionnaire, Peyrot and colleagues only
asked about perceived efficacy of insulin and self-blame for
needing insulin.
Another interesting finding is more patients (40%) with a
high depression score responded that insulin causes weight
gain than those reporting less negative affect (12–14%) In the
UKPDS, patients taking insulin indeed gained 4 kilograms
more than those on diet, over a period of 10 years [4]. Although
modern insulin analogues may have a less profound effect
on weight than NPH [17], worries about gaining weight are
not unrealistic. The fact that depressed patients were the most
worried about the weight issue is in line with the depressive
realism hypothesis, which posits that depressed people are
often more accurate in their perceptions and judgements than
non-depressed people are [18].
There are several limitations that need to be mentioned.
First, as our data have been collected in two Turkish outpatient
clinics in Istanbul, it is important to emphasize that the results
might not be representative for other diabetes patients in or
outside Turkey. Generally the more complex diabetes patients
Table 1 Demographic, clinical and psychological characteristics of male and female participants with type 2 diabetes, who were treated in the 
outpatient clinic of the Istanbul University Hospital or the Cerrahpa!a University Hospital
Istanbul University Hospital Cerrahpa!a University Hospital
Male  Female Male Female
% (n) 48% (47) 52% (51) 41% (23) 59% (33) 
Age (years)  56 ± 10  55 ± 9  60 ± 13  56 ± 9
BMI  27 ± 3  30 ± 5  29 ± 4  31 ± 6
HbA1c 6.8 ± 1.2 6.6 ± 0.9 6.3 ± 0.9 6.6 ± 0.9
Duration of diabetes (years)
< 1 9% (4/47) 2% (1/51) 26% (6/23) 15% (5/33)
1–2 15% (7/47) 16% (8/51) 9% (2/23) 15% (5/33)
3–4 15% (7/47) 20% (10/51) 13% (3/23) 15% (5/33)
5–10 38% (18/47) 41% (21/51) 35% (8/23) 30% (10/33)
> 10 23% (11/47) 22% (11/51) 17% (4/23) 24% (8/33)
Level of education * *
Primary school 2% (1/47) 28% (14/51) 9% (2/23) 46% (15/33)
Middle school 15% (7/47) 6% (3/51) 13% (3/23) 24% (8/33)
College/High school 34% (16/47) 24% (12/51) 30% (7/23) 9% (3/33)
University 49% (23/47) 43% (22/51) 48% (11/23) 21% (7/33)
Diabetes complications
No Complication 60% (28/47) 63% (32/51) 70% (16/23) 64% (21/33)
Retinopathy 9% (4/47) 4% (2/51) 0% (0/23) 6% (2/33)
Cardiovascular 159% (7/47) 14% (7/51) 17% (4/23) 6% (2/33)
Nephropathy 2% (1/47) 6% (3/51) 0% (0/23) 6% (2/33)
Neuropathy 23% (11/47) 24% (12/51) 13% (3/23) 21% (7/33)
Foot problem 13% (6/47) 8% (4.51) 4% (1/23) 9% (3/33)
Mean CES-D score (Depression) 9.7 ± 7.8 11.6 ± 8.9 7.3 ± 8.1 14.3 ± 13.0
High level of depression (CES-D ≥ 16) 13% (6/46) 24% (12/49) 22% (5/23) 40% (13/33)
Mean PAID total score (0–100)  28 ± 23  34 ± 22  30 ± 23  39 ± 24
Mean ITAS total score  52 ± 10  56 ± 9  54 ± 9  53 ± 13
*P ≤ 0.01, comparing men and women within the same hospital.
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are referred to university hospitals, and the patients in our
study were also relatively highly educated.
Secondly, as the design of our study is cross-sectional, we
cannot infer conclusions regarding causality. Yet, it does
seem plausible that depression contributes to a more negative
attitude towards the use of insulin, rather than the reverse.
Furthermore, longitudinal studies are needed to investigate
whether lower levels of depression are predictive of a more
successful change to insulin therapy. Thirdly, we did not collect
data for the patients who refused or were unable to participate
Table 2 Percentages of subjects who responded to each ITAS item with ‘somewhat agree’ or ‘strongly agree’, for each of the patients with different 




n 113 21 15
1-Taking insulin means I have failed to manage my diabetes with diet and tablets. 51% 48% 68%
2-Taking insulin means my diabetes has become much worse. 41% 29% 40%
3-Taking insulin helps to prevent complications of diabetes. 52% 52% 80%
4-Taking insulin means other people see me as a sicker person. 42% 57% 53%
5-Taking insulin makes life less flexible. 43% 38% 53%
6-I’m afraid of injecting myself with a needle. 43% 48% 53%
7-Taking insulin increases the risk of low blood glucose levels (hypoglycaemia). 29% 43% 33%
8-Taking insulin helps to improve my health. 56% 52% 40%
9-Insulin causes weight gain. 12% 14% 40%
10-Managing insulin injections takes a lot of time and energy. 10% 19% 47%**
11-Taking insulin means I have to give up activities I enjoy. 14% 14% 20%
12-Taking insulin means my health will deteriorate. 22% 24% 13%
13-Injecting insulin is embarrassing. 4% 0% 20%*
14-Injecting insulin is painful. 11% 14% 20%
15-It is difficult to inject the right amount of insulin correctly at the right time every day. 27% 29% 53%
16-Taking insulin makes it more difficult to fulfil my responsibilities (at work, at home). 26% 10% 40%
17-Taking insulin helps to maintain good control of blood glucose. 58% 57% 53%
18-Being on insulin causes family and friends to be more concerned about me. 43% 43% 60%
19-Taking insulin helps to improve my energy level. 40% 24% 33%
20-Taking insulin makes me more dependent on my doctor. 34% 43% 53%
*P ≤ 0.05; **P ≤ 0.01.
Table 3 Multiple linear regression analyses: associations between a negative appraisal of insulin therapy (total ITAS score), and 1) sociodemographic 
variables, depression and diabetes-specific emotional distress (PAID survey) in 154 insulin-naive outpatients with type 2 diabetes mellitus
Model 1
Sociodemographic





Beta t P Beta t P Beta t P
I Sociodemographic (enter)
Female sex 0.07 0.81 0.419 0.04 0.53 0.656 0.04 0.45 0.657
Low education 0.15 1.74 0.084 0.14 1.68 0.098 0.11 1.30 0.196
Age (years) −0.04 −0.39 0.694 −0.02 0.05 0.797 0.11 1.20 0.231
Duration diabetes (years) −0.07 −0.79 0.432 −0.11 −1.30 0.208 −0.10 −1.15 0.254
II Depressed mood (enter)
Depression symptoms (CES-D) 0.20 2.30 0.023 0.02 0.25 0.806
III Diabetes-specific emotional distress
Problem Areas In Diabetes Survey (PAID) 0.39 4.12 0.001
Adjusted R2 0.04 0.07 0.17
F-change 1.44 5.31 16.98
P-value (F-change) 0.227 0.023 0.001
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because of reading problems or illiteracy. As a result of this we
have no clear indication if or how the non-response could have
influenced our results. However, we want to emphasize that
the non-response was rather low (30%).
In sum, we can conclude that higher levels of depression
and diabetes-specific emotional distress are associated with a
significantly more negative appraisal of insulin therapy. Future
prospective studies are needed to test whether depression and
diabetes-distress are associated with actual postponing insulin
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